• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺乳头状癌中TGF-α-EGF受体自分泌环及c-myc蛋白过表达的证实

Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.

作者信息

Haugen D R, Akslen L A, Varhaug J E, Lillehaug J R

机构信息

Department of Biochemistry and Molecular Biology, University of Bergen, Norway.

出版信息

Int J Cancer. 1993 Aug 19;55(1):37-43. doi: 10.1002/ijc.2910550108.

DOI:10.1002/ijc.2910550108
PMID:8102129
Abstract

Autocrine growth stimulation has been identified in several types of human cancer. In the present study we wanted to establish whether autocrine stimulation of the epidermal-growth-factor receptor (EGF-r) by its ligand, transforming growth factor alpha (TGF-alpha) occurs in thyroid neoplasia. We examined 190 fresh, frozen thyroid tissue samples from 70 patients by immunohistochemistry with antibodies to EGF-r, TGF-alpha, c-erbB-2 and c-myc. EGF-r expression was detected in 17 out of 19 papillary carcinomas, TGF-alpha expression in 10, and c-erbB-2 expression in 15. No papillary carcinoma expressed TGF-alpha without also expressing EGF-r. Concomitant expression of EGF-r, TGF-alpha and c-erbB-2 was seen in 7 papillary carcinomas. No EGF-r, TGF-alpha or c-erbB-2 immunopositivity was found in normal-appearing thyroid tissue (25 cases), whereas a few of the non-neoplastic lesions (colloid goitres and diffuse hyperplasias) expressed either EGF-r or TGF-alpha. c-myc expression was detectable in all tissue samples, and expression was invariably nuclear. Increased expression was observed in 10 out of 19 papillary carcinomas, and 8 of these also co-expressed EGF-r and TGF-alpha. In situ hybridization confirmed the presence of TGF-alpha mRNA in tumour epithelium of TGF-alpha-immunopositive samples. The concomitant expression of EGF-r, TGF-alpha and TGF-alpha mRNA gives evidence for a TGF-alpha-EGF-r autocrine loop in thyroid papillary carcinomas. The increased c-myc expression may reflect the proliferative advantage of these tumours.

摘要

自分泌生长刺激已在多种人类癌症中得到证实。在本研究中,我们想确定在甲状腺肿瘤中是否存在其配体转化生长因子α(TGF-α)对表皮生长因子受体(EGF-r)的自分泌刺激。我们用针对EGF-r、TGF-α、c-erbB-2和c-myc的抗体,通过免疫组织化学方法检测了70例患者的190份新鲜冷冻甲状腺组织样本。在19例乳头状癌中,17例检测到EGF-r表达,10例检测到TGF-α表达,15例检测到c-erbB-2表达。没有一例乳头状癌在不表达EGF-r的情况下表达TGF-α。7例乳头状癌中同时检测到EGF-r、TGF-α和c-erbB-2的表达。在外观正常的甲状腺组织(25例)中未检测到EGF-r、TGF-α或c-erbB-2免疫阳性,而一些非肿瘤性病变(胶样甲状腺肿和弥漫性增生)表达了EGF-r或TGF-α。在所有组织样本中均检测到c-myc表达,且表达均位于细胞核。在19例乳头状癌中,10例观察到表达增加,其中8例同时还共表达EGF-r和TGF-α。原位杂交证实了TGF-α免疫阳性样本的肿瘤上皮中存在TGF-α mRNA。EGF-r、TGF-α和TGF-α mRNA的同时表达为甲状腺乳头状癌中存在TGF-α-EGF-r自分泌环提供了证据。c-myc表达增加可能反映了这些肿瘤的增殖优势。

相似文献

1
Demonstration of a TGF-alpha-EGF-receptor autocrine loop and c-myc protein over-expression in papillary thyroid carcinomas.甲状腺乳头状癌中TGF-α-EGF受体自分泌环及c-myc蛋白过表达的证实
Int J Cancer. 1993 Aug 19;55(1):37-43. doi: 10.1002/ijc.2910550108.
2
Expression of transforming growth factor alpha and its receptor in human neuroendocrine tumours.转化生长因子α及其受体在人神经内分泌肿瘤中的表达
Int J Cancer. 1995 Mar 3;60(5):645-51. doi: 10.1002/ijc.2910600514.
3
Growth requirements and oncogene expression in the human thyroid cell line SGHTL-34.人甲状腺细胞系SGHTL-34的生长需求及癌基因表达
APMIS. 1993 Oct;101(10):767-76. doi: 10.1111/j.1699-0463.1993.tb00178.x.
4
Abnormalities of the EGF receptor system in human thyroid neoplasia.
Int J Cancer. 1991 Oct 21;49(4):558-61. doi: 10.1002/ijc.2910490414.
5
Expression of c-erbB-2 protein in papillary thyroid carcinomas.c-erbB-2蛋白在甲状腺乳头状癌中的表达。
Br J Cancer. 1992 Jun;65(6):832-7. doi: 10.1038/bjc.1992.177.
6
Expression of epidermal growth factor, transforming growth factor-alpha and epidermal growth factor receptor in thyroid tumors.表皮生长因子、转化生长因子-α及表皮生长因子受体在甲状腺肿瘤中的表达
In Vivo. 1992 May-Jun;6(3):291-6.
7
Clinical significance of oncogenes and growth factors in ovarian carcinomas.
J Steroid Biochem Mol Biol. 1990 Dec 20;37(6):855-62. doi: 10.1016/0960-0760(90)90432-k.
8
Co-expression of epidermal growth factor receptor and transforming growth factor-alpha predicts worse prognosis in breast-cancer patients.表皮生长因子受体与转化生长因子-α的共表达预示着乳腺癌患者的预后更差。
Int J Cancer. 2000 Nov 20;89(6):484-7. doi: 10.1002/1097-0215(20001120)89:6<484::aid-ijc3>3.0.co;2-s.
9
Differential dependence of the tumorigenicity of chemically transformed rat liver epithelial cells on autocrine production of transforming growth factor alpha.化学转化的大鼠肝上皮细胞致瘤性对自分泌转化生长因子α的差异依赖性。
Cell Growth Differ. 1995 Mar;6(3):251-61.
10
Epidermal growth factor and transforming growth factor alpha mRNA expression in human breast cancer biopsies; analysis in relation to estradiol, progesterone and EGF receptor content.人乳腺癌活检组织中表皮生长因子和转化生长因子α mRNA的表达;与雌二醇、孕酮及表皮生长因子受体含量的相关性分析
J Steroid Biochem Mol Biol. 1997 Feb;60(3-4):221-8. doi: 10.1016/s0960-0760(96)00188-4.

引用本文的文献

1
Targeting transcriptional regulators for treatment of anaplastic thyroid cancer.靶向转录调节因子治疗间变性甲状腺癌。
J Cancer Metastasis Treat. 2021;7. doi: 10.20517/2394-4722.2021.58. Epub 2021 May 25.
2
Potentiated anti-tumor effects of BETi by MEKi in anaplastic thyroid cancer.BETi 联合 MEKi 增强甲状腺未分化癌的抗肿瘤作用。
Endocr Relat Cancer. 2019 Sep;26(9):739-750. doi: 10.1530/ERC-19-0107.
3
Synergistic effects of BET and MEK inhibitors promote regression of anaplastic thyroid tumors.BET和MEK抑制剂的协同作用促进间变性甲状腺肿瘤消退。
Oncotarget. 2018 Oct 23;9(83):35408-35421. doi: 10.18632/oncotarget.26253.
4
cMYC expression in thyroid follicular cell-derived carcinomas: a role in thyroid tumorigenesis.cMYC在甲状腺滤泡细胞源性癌中的表达:在甲状腺肿瘤发生中的作用。
Diagn Pathol. 2017 Oct 3;12(1):71. doi: 10.1186/s13000-017-0661-0.
5
miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma.微小RNA-451a在甲状腺乳头状癌中表达下调并靶向AKT/哺乳动物雷帕霉素靶蛋白信号通路。
Oncotarget. 2016 Mar 15;7(11):12731-47. doi: 10.18632/oncotarget.7262.
6
Expressions of D2-40, CK19, galectin-3, VEGF and EGFR in papillary thyroid carcinoma.D2-40、CK19、半乳糖凝集素-3、血管内皮生长因子(VEGF)和表皮生长因子受体(EGFR)在甲状腺乳头状癌中的表达
Gland Surg. 2012 May;1(1):25-32. doi: 10.3978/j.issn.2227-684X.2012.03.02.
7
Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells.肝素结合表皮生长因子样生长因子增强甲状腺癌细胞侵袭和转移的活性。
Oncol Rep. 2013 Oct;30(4):1593-600. doi: 10.3892/or.2013.2659. Epub 2013 Aug 6.
8
EGF and TGF-β1 Effects on Thyroid Function.表皮生长因子和转化生长因子-β1对甲状腺功能的影响。
J Thyroid Res. 2011;2011:431718. doi: 10.4061/2011/431718. Epub 2011 Jun 13.
9
Integrated ligand-receptor bioinformatic and in vitro functional analysis identifies active TGFA/EGFR signaling loop in papillary thyroid carcinomas.整合配体-受体生物信息学和体外功能分析鉴定甲状腺乳头状癌中活跃的 TGFA/EGFR 信号通路。
PLoS One. 2010 Sep 22;5(9):e12701. doi: 10.1371/journal.pone.0012701.
10
Differentiated thyroid cancer cell invasion is regulated through epidermal growth factor receptor-dependent activation of matrix metalloproteinase (MMP)-2/gelatinase A.分化型甲状腺癌细胞的侵袭通过表皮生长因子受体依赖性激活基质金属蛋白酶(MMP)-2/明胶酶A来调节。
Endocr Relat Cancer. 2006 Dec;13(4):1173-83. doi: 10.1677/erc.1.01226.